 | • レポートコード：MRC2102QY6743 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のヒトサイトメガロウイルスエンベロープ糖タンパク質B市場について種類別（CSJ-148、CyMVectin、TRL-345、PPCM、サイトメガロウイルスワクチン、その他）、用途別（感染症、腫瘍、女性健康、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ヒトサイトメガロウイルスエンベロープ糖タンパク質B市場の概要 ・世界の主要地域別ヒトサイトメガロウイルスエンベロープ糖タンパク質B市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のヒトサイトメガロウイルスエンベロープ糖タンパク質B市場規模2015-2026：種類別（CSJ-148、CyMVectin、TRL-345、PPCM、サイトメガロウイルスワクチン、その他） ・世界のヒトサイトメガロウイルスエンベロープ糖タンパク質B市場規模2015-2026：用途別（感染症、腫瘍、女性健康、その他） ・ヒトサイトメガロウイルスエンベロープ糖タンパク質Bの米国市場規模2015-2020 ・ヒトサイトメガロウイルスエンベロープ糖タンパク質Bのヨーロッパ市場規模2015-2020 ・ヒトサイトメガロウイルスエンベロープ糖タンパク質Bの中国市場規模2015-2020 ・ヒトサイトメガロウイルスエンベロープ糖タンパク質Bの日本市場規模2015-2020 ・ヒトサイトメガロウイルスエンベロープ糖タンパク質Bの東南アジア市場規模2015-2020 ・ヒトサイトメガロウイルスエンベロープ糖タンパク質Bのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・ヒトサイトメガロウイルスエンベロープ糖タンパク質Bの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ヒトサイトメガロウイルスエンベロープ糖タンパク質Bの市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Human Cytomegalovirus Envelope Glycoprotein B Market
The global Human Cytomegalovirus Envelope Glycoprotein B market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Human Cytomegalovirus Envelope Glycoprotein B Scope and Market Size
The global Human Cytomegalovirus Envelope Glycoprotein B market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Cytomegalovirus Envelope Glycoprotein B market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Human Cytomegalovirus Envelope Glycoprotein B market is segmented into
CSJ-148
CyMVectin
TRL-345
PPCM
Cytomegalovirus Vaccine
Others
Segment by Application, the Human Cytomegalovirus Envelope Glycoprotein B market is segmented into
Infectious Disease
Oncology
Women’s Health
Others
The Human Cytomegalovirus Envelope Glycoprotein B market is analysed and market size information is provided by regions (countries). Segment by Application, the Human Cytomegalovirus Envelope Glycoprotein B market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Human Cytomegalovirus Envelope Glycoprotein B Market Share Analysis
Human Cytomegalovirus Envelope Glycoprotein B market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Cytomegalovirus Envelope Glycoprotein B business, the date to enter into the Human Cytomegalovirus Envelope Glycoprotein B market, Human Cytomegalovirus Envelope Glycoprotein B product introduction, recent developments, etc.
The major vendors covered:
Astellas Pharma Inc.
Trellis Bioscience, Inc.
Vakzine Projekt Management GmbH
VBI Vaccine Inc
Vical Incorporated
1 Human Cytomegalovirus Envelope Glycoprotein B Market Overview
1.1 Human Cytomegalovirus Envelope Glycoprotein B Product Scope
1.2 Human Cytomegalovirus Envelope Glycoprotein B Segment by Type
1.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2020-2026)
1.2.2 CSJ-148
1.2.3 CyMVectin
1.2.4 TRL-345
1.2.5 PPCM
1.2.6 Cytomegalovirus Vaccine
1.2.7 Others
1.3 Human Cytomegalovirus Envelope Glycoprotein B Segment by Application
1.3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Comparison by Application (2020-2026)
1.3.2 Infectious Disease
1.3.3 Oncology
1.3.4 Women’s Health
1.3.5 Others
1.4 Human Cytomegalovirus Envelope Glycoprotein B Market Estimates and Forecasts (2015-2026)
1.4.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate (2015-2026)
1.4.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate (2015-2026)
1.4.3 Global Human Cytomegalovirus Envelope Glycoprotein B Price Trends (2015-2026)
2 Human Cytomegalovirus Envelope Glycoprotein B Estimate and Forecast by Region
2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2015-2020)
2.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region (2015-2020)
2.3 Global Human Cytomegalovirus Envelope Glycoprotein B Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Human Cytomegalovirus Envelope Glycoprotein B Estimates and Projections (2015-2026)
2.4.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Estimates and Projections (2015-2026)
2.4.3 China Human Cytomegalovirus Envelope Glycoprotein B Estimates and Projections (2015-2026)
2.4.4 Japan Human Cytomegalovirus Envelope Glycoprotein B Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Estimates and Projections (2015-2026)
2.4.6 India Human Cytomegalovirus Envelope Glycoprotein B Estimates and Projections (2015-2026)
3 Global Human Cytomegalovirus Envelope Glycoprotein B Competition Landscape by Players
3.1 Global Top Human Cytomegalovirus Envelope Glycoprotein B Players by Sales (2015-2020)
3.2 Global Top Human Cytomegalovirus Envelope Glycoprotein B Players by Revenue (2015-2020)
3.3 Global Human Cytomegalovirus Envelope Glycoprotein B Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Cytomegalovirus Envelope Glycoprotein B as of 2019)
3.4 Global Human Cytomegalovirus Envelope Glycoprotein B Average Price by Company (2015-2020)
3.5 Manufacturers Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Human Cytomegalovirus Envelope Glycoprotein B Players (Opinion Leaders)
4 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size by Type
4.1 Global Human Cytomegalovirus Envelope Glycoprotein B Historic Market Review by Type (2015-2020)
4.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2015-2020)
4.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Type (2015-2020)
4.1.3 Global Human Cytomegalovirus Envelope Glycoprotein B Price by Type (2015-2020)
4.2 Global Human Cytomegalovirus Envelope Glycoprotein B Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Type (2021-2026)
4.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Type (2021-2026)
4.2.3 Global Human Cytomegalovirus Envelope Glycoprotein B Price Forecast by Type (2021-2026)
5 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size by Application
5.1 Global Human Cytomegalovirus Envelope Glycoprotein B Historic Market Review by Application (2015-2020)
5.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2015-2020)
5.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application (2015-2020)
5.1.3 Global Human Cytomegalovirus Envelope Glycoprotein B Price by Application (2015-2020)
5.2 Global Human Cytomegalovirus Envelope Glycoprotein B Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Application (2021-2026)
5.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Application (2021-2026)
5.2.3 Global Human Cytomegalovirus Envelope Glycoprotein B Price Forecast by Application (2021-2026)
6 United States Human Cytomegalovirus Envelope Glycoprotein B Market Facts & Figures
6.1 United States Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Company (2015-2020)
6.2 United States Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2015-2020)
6.3 United States Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2015-2020)
7 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Facts & Figures
7.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Company (2015-2020)
7.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2015-2020)
7.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2015-2020)
8 China Human Cytomegalovirus Envelope Glycoprotein B Market Facts & Figures
8.1 China Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Company (2015-2020)
8.2 China Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2015-2020)
8.3 China Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2015-2020)
9 Japan Human Cytomegalovirus Envelope Glycoprotein B Market Facts & Figures
9.1 Japan Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Company (3015-3030)
9.2 Japan Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2015-2020)
9.3 Japan Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2015-2020)
10 Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Market Facts & Figures
10.1 Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2015-2020)
11 India Human Cytomegalovirus Envelope Glycoprotein B Market Facts & Figures
11.1 India Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Company (2015-2020)
11.2 India Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2015-2020)
11.3 India Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Human Cytomegalovirus Envelope Glycoprotein B Business
12.1 Astellas Pharma Inc.
12.1.1 Astellas Pharma Inc. Corporation Information
12.1.2 Astellas Pharma Inc. Business Overview
12.1.3 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Products Offered
12.1.5 Astellas Pharma Inc. Recent Development
12.2 Trellis Bioscience, Inc.
12.2.1 Trellis Bioscience, Inc. Corporation Information
12.2.2 Trellis Bioscience, Inc. Business Overview
12.2.3 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Products Offered
12.2.5 Trellis Bioscience, Inc. Recent Development
12.3 Vakzine Projekt Management GmbH
12.3.1 Vakzine Projekt Management GmbH Corporation Information
12.3.2 Vakzine Projekt Management GmbH Business Overview
12.3.3 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Products Offered
12.3.5 Vakzine Projekt Management GmbH Recent Development
12.4 VBI Vaccine Inc
12.4.1 VBI Vaccine Inc Corporation Information
12.4.2 VBI Vaccine Inc Business Overview
12.4.3 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Gross Margin (2015-2020)
12.4.4 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Products Offered
12.4.5 VBI Vaccine Inc Recent Development
12.5 Vical Incorporated
12.5.1 Vical Incorporated Corporation Information
12.5.2 Vical Incorporated Business Overview
12.5.3 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Products Offered
12.5.5 Vical Incorporated Recent Development
…
13 Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Cost Analysis
13.1 Human Cytomegalovirus Envelope Glycoprotein B Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Human Cytomegalovirus Envelope Glycoprotein B
13.4 Human Cytomegalovirus Envelope Glycoprotein B Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Human Cytomegalovirus Envelope Glycoprotein B Distributors List
14.3 Human Cytomegalovirus Envelope Glycoprotein B Customers
15 Market Dynamics
15.1 Human Cytomegalovirus Envelope Glycoprotein B Market Trends
15.2 Human Cytomegalovirus Envelope Glycoprotein B Opportunities and Drivers
15.3 Human Cytomegalovirus Envelope Glycoprotein B Market Challenges
15.4 Human Cytomegalovirus Envelope Glycoprotein B Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Human Cytomegalovirus Envelope Glycoprotein B Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Region (2015-2020)
Table 5. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2015-2020)
Table 6. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Region (2015-2020)
Table 8. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Share Forecast by Region (2021-2026)
Table 12. Global Human Cytomegalovirus Envelope Glycoprotein B (K Pcs) of Key Companies (2015-2020)
Table 13. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Company (2015-2020)
Table 14. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Company (2015-2020)
Table 16. Global Human Cytomegalovirus Envelope Glycoprotein B by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Cytomegalovirus Envelope Glycoprotein B as of 2019)
Table 17. Global Human Cytomegalovirus Envelope Glycoprotein B Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Sites and Area Served
Table 19. Manufacturers Human Cytomegalovirus Envelope Glycoprotein B Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Human Cytomegalovirus Envelope Glycoprotein B Players
Table 22. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Type (2015-2020)
Table 23. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Type (2015-2020)
Table 24. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Human Cytomegalovirus Envelope Glycoprotein B Price (K Pcs) by Type (2015-2020)
Table 26. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Type (2021-2026)
Table 27. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Type (2021-2026)
Table 29. Global Human Cytomegalovirus Envelope Glycoprotein B Price (K Pcs) by Type (2021-2026)
Table 30. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Application (2015-2020)
Table 31. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Application (2015-2020)
Table 32. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Human Cytomegalovirus Envelope Glycoprotein B Price (K Pcs) by Application (2015-2020)
Table 34. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Application (2021-2026)
Table 35. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Application (2021-2026)
Table 36. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Application (2021-2026)
Table 38. Global Human Cytomegalovirus Envelope Glycoprotein B Price (K Pcs) by Application (2021-2026)
Table 39. United States Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Company (2015-2020)
Table 40. United States Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Company (2015-2020)
Table 41. United States Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Type (2015-2020)
Table 42. United States Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2015-2020)
Table 43. United States Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Application (2015-2020)
Table 44. United States Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2015-2020)
Table 45. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Company (2015-2020)
Table 47. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2015-2020)
Table 49. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2015-2020)
Table 51. China Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Company (2015-2020)
Table 52. China Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Company (2015-2020)
Table 53. China Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Type (2015-2020)
Table 54. China Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2015-2020)
Table 55. China Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Application (2015-2020)
Table 56. China Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2015-2020)
Table 57. Japan Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Company (2015-2020)
Table 59. Japan Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2015-2020)
Table 61. Japan Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2015-2020)
Table 69. India Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Company (2015-2020)
Table 70. India Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Company (2015-2020)
Table 71. India Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Type (2015-2020)
Table 72. India Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2015-2020)
Table 73. India Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Application (2015-2020)
Table 74. India Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2015-2020)
Table 75. Astellas Pharma Inc. Corporation Information
Table 76. Astellas Pharma Inc. Description and Business Overview
Table 77. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product
Table 79. Astellas Pharma Inc. Recent Development
Table 80. Trellis Bioscience, Inc. Corporation Information
Table 81. Trellis Bioscience, Inc. Description and Business Overview
Table 82. Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Product
Table 84. Trellis Bioscience, Inc. Recent Development
Table 85. Vakzine Projekt Management GmbH Corporation Information
Table 86. Vakzine Projekt Management GmbH Description and Business Overview
Table 87. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product
Table 89. Vakzine Projekt Management GmbH Recent Development
Table 90. VBI Vaccine Inc Corporation Information
Table 91. VBI Vaccine Inc Description and Business Overview
Table 92. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product
Table 94. VBI Vaccine Inc Recent Development
Table 95. Vical Incorporated Corporation Information
Table 96. Vical Incorporated Description and Business Overview
Table 97. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product
Table 99. Vical Incorporated Recent Development
Table 100. Production Base and Market Concentration Rate of Raw Material
Table 101. Key Suppliers of Raw Materials
Table 102. Human Cytomegalovirus Envelope Glycoprotein B Distributors List
Table 103. Human Cytomegalovirus Envelope Glycoprotein B Customers List
Table 104. Human Cytomegalovirus Envelope Glycoprotein B Market Key Trends
Table 105. Human Cytomegalovirus Envelope Glycoprotein B Key Opportunities and Drivers
Table 106. Human Cytomegalovirus Envelope Glycoprotein B Market Challenges
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Cytomegalovirus Envelope Glycoprotein B Product Picture
Figure 2. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Human Cytomegalovirus Envelope Glycoprotein B Market Share by Application in 2020 & 2026
Figure 6. Infectious Disease Examples
Figure 7. Oncology Examples
Figure 8. Women's Health Examples
Figure 9. Others Examples
Figure 10. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) Growth Rate (2015-2026)
Figure 11. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Human Cytomegalovirus Envelope Glycoprotein B Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 13. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) Growth Rate (2015-2026)
Figure 17. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Human Cytomegalovirus Envelope Glycoprotein B Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Human Cytomegalovirus Envelope Glycoprotein B Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Human Cytomegalovirus Envelope Glycoprotein B Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Human Cytomegalovirus Envelope Glycoprotein B Players Market Share by Revenue in Human Cytomegalovirus Envelope Glycoprotein B 2015 & 2019
Figure 28. Human Cytomegalovirus Envelope Glycoprotein B Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Type (2015-2020)
Figure 30. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Application (2015-2020)
Figure 32. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type in 2019
Figure 34. United States Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type in 2019
Figure 35. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Company in 2019
Figure 36. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type in 2019
Figure 37. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application in 2019
Figure 38. China Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Company in 2019
Figure 39. China Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type in 2019
Figure 40. China Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application in 2019
Figure 41. Japan Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Company in 2019
Figure 42. Japan Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type in 2019
Figure 43. Japan Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application in 2019
Figure 44. Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Company in 2019
Figure 45. Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type in 2019
Figure 46. Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application in 2019
Figure 47. India Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Company in 2019
Figure 48. India Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type in 2019
Figure 49. India Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Human Cytomegalovirus Envelope Glycoprotein B
Figure 52. Manufacturing Process Analysis of Human Cytomegalovirus Envelope Glycoprotein B
Figure 53. Human Cytomegalovirus Envelope Glycoprotein B Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
糖タンパク質41の世界市場レポート2020 Market Analysis and Insights: Global Glycoprotein 41 Market The global Glycoprotein 41 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Glycoprotein 41 Scope and Market Size The global Glycoprotein 41 market is segmented…- ヒト用予防ワクチンの世界市場レポート2020 Vaccination in the body of a healthy person causes the person to produce antibodies and obtain specific immunity in the absence of disease. For example, BCG vaccination, smallpox vaccination and so on. Market Analysis and Insights: Global Prophylactic Human Vaccine Market The global Prophylactic Hum…
- ヒト凝固因子VIIの世界市場レポート2020 Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. A bio similar form of recombinant activa…
- ヒト用ワクチンの世界市場レポート2020 A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. China …
- ヒトエンドスタチンの世界市場レポート2020 Endostatin is a naturally occurring, 20-kDa C-terminal fragment derived from type XVIII collagen. Human monomeric endostatin is a globular protein containing two disulfide bonds: Cys162−302 and Cys264−294. Market Analysis and Insights: Global Human Endostatin Market The global Human Endostatin marke…